Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway - Liao, Weili; Fan, Rui; Du, Yuman; Wang, Hairong; Yang, Yong; Tian, Yuan (Frontiers in Pharmacology, 2026)